or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 220.06 1.33% 2.89
    MDGL closed up 1.33 percent on Friday, May 17, 2024, on 45 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    Up 3 Days in a Row Strength 0.00%
    20 DMA Support Bullish 1.33%
    Inside Day Range Contraction 1.33%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.93%
    Crossed Above 20 DMA Bullish 3.93%
    Inside Day Range Contraction 3.93%
    Gapped Up Strength 3.93%
    20 DMA Resistance Bearish 4.30%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.30%
    Gapped Up Strength 4.30%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 1 day ago
    Possible NR7 1 day ago
    Up 1% 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 17 3 High Insider Ownership US Stocks With Up To 55% Revenue Growth
    May 16 John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role
    May 8 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
    May 8 Madrigal Pharmaceuticals Inc (MDGL) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
    May 7 Madrigal Pharmaceuticals (MDGL) Q1 2024 Earnings Call Transcript
    May 7 Madrigal sees ‘tremendous interest’ in new NASH drug Rezdiffra
    May 7 Madrigal Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Rezdiffra Launch
    May 7 Madrigal Pharmaceuticals GAAP EPS of -$7.38 misses by $1.18
    May 7 Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
    May 6 Madrigal Pharmaceuticals Q1 2024 Earnings Preview
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 302.68
    52 Week Low 119.7604
    Average Volume 523,477
    200-Day Moving Average 201.76
    50-Day Moving Average 234.20
    20-Day Moving Average 211.54
    10-Day Moving Average 214.50
    Average True Range 11.49
    RSI (14) 50.74
    ADX 14.53
    +DI 23.43
    -DI 23.41
    Chandelier Exit (Long, 3 ATRs) 202.18
    Chandelier Exit (Short, 3 ATRs) 223.47
    Upper Bollinger Bands 231.75
    Lower Bollinger Band 191.33
    Percent B (%b) 0.71
    BandWidth 19.11
    MACD Line -4.22
    MACD Signal Line -6.09
    MACD Histogram 1.8751
    Fundamentals Value
    Market Cap 4.34 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -11.44
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 229.81
    Resistance 3 (R3) 229.21 225.37 228.18
    Resistance 2 (R2) 225.37 222.88 225.66 227.64
    Resistance 1 (R1) 222.71 221.35 224.04 223.31 227.10
    Pivot Point 218.87 218.87 219.53 219.16 218.87
    Support 1 (S1) 216.21 216.38 217.54 216.81 213.02
    Support 2 (S2) 212.37 214.85 212.67 212.48
    Support 3 (S3) 209.71 212.37 211.94
    Support 4 (S4) 210.31